Aleph Farms augmente ses capacits de production grce lacquisition de linstallation de VBL Therapeutics et au partenariat ESCO Aster
| VBLTDelisted Stock | USD 0.28 0.01 3.45% |
Slightly above 61% of Vascular Biogenics' investor base is looking to short. The analysis of current outlook of investing in Vascular Biogenics suggests that many traders are alarmed regarding Vascular Biogenics' prospects. Vascular Biogenics' investing sentiment can be driven by a variety of factors including economic data, Vascular Biogenics' earnings reports, geopolitical events, and overall market trends.
Vascular |
Aleph Farms, la premire entreprise cultiver des steaks directement partir de cellules de vache non modifies, a annonc aujourdhui quelle avait
Read at businesswire.com
 |
Vascular Biogenics Fundamental Analysis
We analyze Vascular Biogenics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vascular Biogenics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vascular Biogenics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Earnings Per Share
Earnings Per Share Comparative Analysis
Vascular Biogenics is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Vascular Biogenics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vascular Biogenics stock to make a market-neutral strategy. Peer analysis of Vascular Biogenics could also be used in its relative valuation, which is a method of valuing Vascular Biogenics by comparing valuation metrics with similar companies.
Peers
Vascular Biogenics Related Equities
| XFOR | X4 Pharmaceuticals | 10.87 | ||||
| ATXI | Avenue Therapeutics | 5.71 | ||||
| RNAZ | Transcode Therapeutics | 5.02 | ||||
| ZVSA | ZyVersa Therapeutics | 4.23 | ||||
| ABOS | Acumen Pharmaceuticals | 2.48 | ||||
| ALLR | Allarity Therapeutics | 1.94 | ||||
| VRAX | Virax Biolabs | 1.87 | ||||
| DAWN | Day One | 1.13 | ||||
| HOOK | Hookipa Pharma | 0.52 | ||||
| INZY | Inozyme Pharma | 1.45 | ||||
| TERN | Terns Pharmaceuticals | 1.56 | ||||
| ZURA | Zura Bio | 1.67 | ||||
| REVB | Revelation Biosciences | 2.44 | ||||
| PHIO | Phio Pharmaceuticals | 10.47 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Vascular Stock
If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |